MedPlus Health Services share price
You have to be logged in to add this to Watchlist.- ₹784.20(-1.82%)January 21, 2026 15:29:01 PM IST
- NSE
- BSE
- Vol : 194.71 K (NSE + BSE)Last 20 day avg : 87.72 K
MedPlus Health Services is trading -1.82% lower at Rs 784.20 as compared to its last closing price. MedPlus Health Services has been trading in the price range of 793.65 & 781.10. MedPlus Health Services has given -0.76% in this year & -5.33% in the last 5 days. MedPlus Health Services has TTM P/E ratio 46.47 as compared to the sector P/E of 23.93.There are 6 analysts who have initiated coverage on MedPlus Health Services. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 55.50 Crores in its last quarter.Listed peers of MedPlus Health Services include Novelix Pharmaceuticals (-1.85%), Muller & Phipps India Ltd (-2.71%).The Mutual Fund holding in MedPlus Health Services was at 21.48% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in MedPlus Health Services was at 16.83% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 22, 2026, 01:16 AM UTC
- BetaLow volatility0.61Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.64The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation3.59The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Novelix Pharmaceuticals | Neutral | 53.00 | -1.85 | 85.55 | 619.57 | 2.66 | - | - |
| Muller & Phipps India Ltd | Bearish | 210.00 | -2.71 | 12.88 | - | - | - |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-08-02 | Quarterly Results |
| 2025-05-27 | Audited Results |
| 2025-01-31 | Quarterly Results |
- IndustryRetail (Drugs)
- ISININE804L01022
- BSE Code543427
- NSE CodeMEDPLUS
MedPlus Health Services is trading at 784.20 as on Wed Jan 21 2026 09:59:01. This is -1.82% lower as compared to its previous closing price of 798.75.
The market capitalization of MedPlus Health Services is 9423.03 Cr as on Wed Jan 21 2026 09:59:01.
The average broker rating on MedPlus Health Services is Strong Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for MedPlus Health Services is 1052.05 whereas the 52 wk low is 603.00
MedPlus Health Services can be analyzed on the following key metrics -
- TTM P/E: 46.47
- Sector P/E: 23.93
- Dividend Yield: 0.00%
- D/E ratio: 0.65
MedPlus Health Services reported a net profit of 150.32 Cr in 2025.
The Mutual Fund Shareholding was 21.48% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
MedPlus Health Services QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.